Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Trends in Pharmacological Sciences
|
May 15, 2002
Functional versus chemical diversity: is biodiversity important for drug discovery?
Martin Tulp, Lars Bohlin
Trends in Pharmacological Sciences
|
April 6, 2005
Rediscovery of known natural compounds: nuisance or goldmine?
Martin Tulp, Lars Bohlin
Bioorganic & Medicinal Chemistry
|
July 16, 2005
Rediscovery of known natural compounds: nuisance or goldmine?
Martin Tulp, Lars Bohlin
Drug Discovery Today
|
April 28, 2004
Unconventional natural sources for future drug discovery
Martin Tulp, Lars Bohlin
Drug Discovery Today
|
November 30, 2006
Food for thought
Martin Tulp, Jan G Bruhn, Lars Bohlin
Acta Pharmacologica Sinica
|
July 26, 2005
Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
Cheng Luo, Ming-liang He, Lars Bohlin
Phytochemical Analysis : PCA
|
September 11, 2013
Bioassays in natural product research - strategies and methods in the search for anti-inflammatory and antimicrobial activity
Adam A Strömstedt, Jenny Felth, Lars Bohlin
Current Protein & Peptide Science
|
November 17, 2004
Novel strategies for isolation and characterization of cyclotides: the discovery of bioactive macrocyclic plant polypeptides in the Violaceae
Ulf Göransson, Erika Svangård, Per Claeson, et al.
Journal of Natural Products
|
July 26, 2005
Expanding the ChemGPS chemical space with natural products
Josefin Larsson, Johan Gottfries, Lars Bohlin, et al.
Progress in Molecular and Subcellular Biology
|
February 27, 2017
35 Years of Marine Natural Product Research in Sweden: Cool Molecules and Models from Cold Waters
Lars Bohlin, Paco Cárdenas, Anders Backlund, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Trends in Pharmacological Sciences
|
May 15, 2002
Functional versus chemical diversity: is biodiversity important for drug discovery?
Martin Tulp, Lars Bohlin
Trends in Pharmacological Sciences
|
April 6, 2005
Rediscovery of known natural compounds: nuisance or goldmine?
Martin Tulp, Lars Bohlin
Bioorganic & Medicinal Chemistry
|
July 16, 2005
Rediscovery of known natural compounds: nuisance or goldmine?
Martin Tulp, Lars Bohlin
Drug Discovery Today
|
April 28, 2004
Unconventional natural sources for future drug discovery
Martin Tulp, Lars Bohlin
Drug Discovery Today
|
November 30, 2006
Food for thought
Martin Tulp, Jan G Bruhn, Lars Bohlin
Acta Pharmacologica Sinica
|
July 26, 2005
Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
Cheng Luo, Ming-liang He, Lars Bohlin
Phytochemical Analysis : PCA
|
September 11, 2013
Bioassays in natural product research - strategies and methods in the search for anti-inflammatory and antimicrobial activity
Adam A Strömstedt, Jenny Felth, Lars Bohlin
Current Protein & Peptide Science
|
November 17, 2004
Novel strategies for isolation and characterization of cyclotides: the discovery of bioactive macrocyclic plant polypeptides in the Violaceae
Ulf Göransson, Erika Svangård, Per Claeson, et al.
Journal of Natural Products
|
July 26, 2005
Expanding the ChemGPS chemical space with natural products
Josefin Larsson, Johan Gottfries, Lars Bohlin, et al.
Progress in Molecular and Subcellular Biology
|
February 27, 2017
35 Years of Marine Natural Product Research in Sweden: Cool Molecules and Models from Cold Waters
Lars Bohlin, Paco Cárdenas, Anders Backlund, et al.
Page
of 6